Philadelphia University + Thomas Jefferson University

Parvizi, Javad

< Back



Javad Parvizi, MD, FRCS

Contact Dr. Parvizi

925 Chestnut Street
5th Floor
Philadelphia, PA 19107

(800) 321-9999

Medical School

University of Sheffield, United Kingdom - 1991


Mayo Medical Center, Rochester MN


Mayo Medical Center, Rochester MN
University of Berne, Switzerland

Board Certification

Orthopaedic Surgery

Hospital Appointment

Thomas Jefferson University Hospital

Expertise and Research Interests

Dr. Parvizi is a board certified orthopaedic surgeon specializing in pelvis, hip, and knee reconstruction with a special interest in hip pain in young adults and joint preservation procedures. He is the director of Clinical Research at the Rothman Institute.

Dr. Parvizi completed his medical training in the United Kingdom graduating from University of Sheffield in 1991. He completed his surgical training at the Mayo Clinic in Rochester, MN and fellowship training with Professor Reinhold Ganz in Iselspital, Switzerland. His training also includes a master''s degree from the Mayo Foundation in Molecular Biology that involved evaluating bone healing and cartilage repair.

Dr. Parvizi brings a new and unique expertise for treatment of hip pain in young adults, which includes Ganz''s Periacetabular Osteotomy and other non-replacement surgeries for the hip.

He is a member of various societies including the American Academy of Orthopaedic Surgeons and the Orthopaedic Research Society. He is actively involved in basic science research particularly related to Smart Self-Protective Implants that resist infection.


Most Recent Peer-Reviewed Publications

  1. Diagnosis of Streptococcus canis periprosthetic joint infection: the utility of next-generation sequencing
  2. Can next generation sequencing play a role in detecting pathogens in synovial fluid?
  3. Are All Periprosthetic Joint Infections the Same? Evaluating Major vs Minor Criteria
  4. Infection Following Total Joint Arthroplasty Is the Main Cause of Litigation: Data From One Metropolitan Area
  5. Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: Aspirin versus warfarin
  6. The Alpha-Defensin Test for Diagnosing Periprosthetic Joint Infection in the Setting of an Adverse Local Tissue Reaction Secondary to a Failed Metal-on-Metal Bearing or Corrosion at the Head-Neck Junction
  7. Total knee arthroplasty in patients with retention of prior hardware material: What is the outcome?
  8. Treatment of the Acute and Chronic Infected Total Ankle Arthroplasty
  9. Management of periprosthetic joint infection
  10. What Are the Frequency, Associated Factors, and Mortality of Amputation and Arthrodesis After a Failed Infected TKA?
  11. Introduction
  12. Clinical aspects: Clinical aspects of prosthetic joint infection
  13. Serum Fructosamine: A Simple and Inexpensive Test for Assessing Preoperative Glycemic Control
  14. A murine model for developmental dysplasia of the hip: Ablation of CX3CR1 affects acetabular morphology and gait
  15. Environment of care: Is it time to reassess microbial contamination of the operating room air as a risk factor for surgical site infection in total joint arthroplasty?
  16. Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: Commonly asked questions
  17. Serum D-Dimer Test Is Promising for the Diagnosis of Periprosthetic Joint Infection and Timing of Reimplantation
  18. Reactive scoliosis: a challenging phenomenon in adolescent patients with hip arthritis
  19. Optimizing Mechanical Alignment With Modular Stems in Revision TKA
  20. Diagnosing Periprosthetic Joint Infection: And the Winner Is?